Clinical impact of occult HBV infections

Journal of Clinical Virology

Volumn 34, Issue SUPPL. 1, 2005, Pages

  Chemin, I ^a   Trepo C ^a,b  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

Author keywords

HBs antigenemia; Hepatitis B; Occult; Pathogenicity

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ACUTE HEPATITIS; ALCOHOL LIVER DISEASE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CHRONIC HEPATITIS; GEOGRAPHIC DISTRIBUTION; HEMODIALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; VIRUS CARCINOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 32044440319     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(05)80005-8     Document Type: Article

References (74)

1. Jul Alexopoulou A., Karayiannis P., Hadziyannis S.J., Hou J., Pickering J., Luo K., and Thomas H.C. Whole genome analysis of hepatitis B virus from four cases of fulminant hepatitis: genetic variability and its potential role in disease pathogenicity J Viral Hepat 3 4 1996 173 181
2. Mar-Apr Baginski I., Chemin I., Hantz O., Pichoud C., Jullien A.M., Chevre J.C., and Li J.S. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis Transfusion 32 3 1992 215 220
3. Bellentani S., Tiribelli C., Saccoccio G., Sodde M., Fratti N., and De Martin C. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos study Hepatology 6 1994 1442 1449
4. Sep Berasain C., Betes M., Panizo A., Ruiz J., Herrero J.I., Civeira M.P., and Prieto J. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology Gut 47 3 2000 429 435
5. Dec Blackberg J., and Kidd-Ljunggren K. Occult hepatitis B virus after acute selflimited infection persisting for 30 years without sequence variation J Hepatol 33 6 2000 992 997
6. Nov Bréchot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms Review Gastroenterology 127 5 2004 556 561 Review
7. Bréchot C., Pourcel C., Louise A., Rain B., and Tiollais P. Detection of hepatitis B virus DNA sequences in human hepatocellular carcinoma in an integrated form Prog Med Viral 27 1981 99 102
8. Sep Cabrerizo M., Bartolome J., De Sequera P., Caramelo C., and Carreno V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigennegative hemodialysis patients and staff J Am Soc Nephrol 8 9 1997 1443 1447
9. Jul Cabrerizo M., Bartolome J., Caramelo C., Barril G., and Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases Hepatology 32 1 2000 116 123
10. Jul 1 Cacciola I., Pollicino T., Squadrito G., Cerenzia G., Orlando M.E., and Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease N Engl J Med 341 1 1999 22 26
11. Aug 11 Carman W.E., Zanetti A.R., Karayiannis P., Waters J., Manzillo G., Tanzi E., and Zuckerman A.J. Vaccine-induced escape mutant of hepatitis B virus Lancet 336 8711 1990 325 329
12. Dec Carman W.E., Van Deursen F.J., Mimms L.T., Hardie D., Coppola R., Decker R., and Sanders R. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia Hepatology 26 6 1997 1658 1666
13. Nov Chaudhuri V., Tayal R., Nayak B., Acharya S.K., and Panda S.K. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter Gastroenterology 127 5 2004 1356 1371
14. Jan 15 Chazouillères O., Mamish D., Kim M., Carey K., Ferrell L., Roberts J.P., and Ascher N.L. "Occult" hepatitis B virus as source of infection in liver transplant recipients Lancet 343 8890 1994 142 146
15. Nov Chemin I., Jeantet D., Kay A., and Trepo C. Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease Review Antiviral Res 52 2 2001 117 123
16. Mar Chemin I., Zoulim F., Merle P., Arkhis A., Chevallier M., and Kay A. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology J Hepatol 34 3 2001 447 454
17. Jul Chung R.T., Feng S., and Delmonico F.L. Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor Am J Transplant 1 2 2001 185 191
18. Jul Coffin C.S., and Michalak T.I. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis J Clin Invest 104 2 1999 203 212
19. Jul Conjeevaram H.S., and Lok A.S. Occult hepatitis B virus infection: a hidden menace? Hepatology 34 1 2001 204 206
20. Dec De Maria N., Colantoni A., Friedlander L., Leandro G., Idilman R., Harig J., and Van Thiel D.H. The impact of previous HBV infection on the course of chronic hepatitis C Am J Gastroenterol 95 12 2000 3529 3536
21. Feb Feray C., Gigou M., Samuel D., Reyes G., Bernuau J., Reynes M., and Bismuth H. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis Gastroenterology 104 2 1993 549 555
22. Fukuda R., Ishimura N., Kushiyama Y., Moriyama N., Ishihara S., Chowdhury A., and Tokuda A. Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis Microbiol Immunol 40 7 1996 481 488
23. Jul Fukuda R., Ishimura N., Niigaki M., Hamamoto S., Satoh S., Tanaka S., and Kushiyama Y. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance J Med Virol 58 3 1999 201 207
24. Mar Fukuda R., Ishimura N., Hamamoto S., Moritani M., Uchida Y., Ishihara S., and Akagi S. Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver J Med Virol 63 3 2001 220 227
25. Fuster J., Garcia-Valdecasas J.C., Grande L., Tabet J., Bruix J., and Anglada T. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series Ann Surg 3 1996 297 302
26. Oct Hsu H.Y., Chang M.H., Ni Y.H., and Chen H.L. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan Gut 53 10 2004 1499 1503
27. May Hunt C.M., McGill J.M., Allen M.I., and Condreay L.D. Clinical relevance of hepatitis B viral mutations Review Hepatology 31 5 2000 1037 1044
28. Nov Hytiroglou P., Dash S., Haruna Y., Fernandez M., Theise N.D., Schwartz M., and Miller C. Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology Am J Clin Pathol 104 5 1995 588 593
29. Jan Iwai K., Tashima M., Itoh M., Okazaki T., Yamamoto K., Ohno H., and Marusawa H. Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period Bone Marrow Transplant 25 1 2000 105 108
30. Aug Jeantet D., Chemin I., Mandrand B., Tran A., Zoulim F., Merle P., and Trepo C. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays J Med Virol 73 4 2004 508 515
31. Review Jilg W. Significance of imported hepatitis B virus infections Arch Virol Suppl 11 1996 181 183
32. Dec Kobayashi S., Saigoh K., Urashima T., Asano T., and Isono K. Detection of hepatitis B virus x transcripts in human hepatocellular carcinoma tissues J Surg Res 73 2 1997 97 100
33. Jan Koike K. Review. Japanese Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis Nippon Rinsho 57 1 1999 213 219
34. Apr Koike K., Kobayashi M., Gondo M., Hayashi I., Osuga T., and Takada S. Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients J Med Virol 54 4 1998 249 255
35. Liang T.J., Baruch Y., Ben-Porath E., Enat R., Bassan L., and Brown N.V. Hepatitis B virus infection in patients with idiopathic liver disease Hepatology 13 1991 1044 1051
36. Apr Lo Y.M., Lo E.S., Mehal W.Z., Sampietro M., Fiorelli G., Ronchi G., and Tse C.H. Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients J Clin Pathol 46 4 1993 304 308
37. Jan Lok A.S., Liang R.I.L., Chiu E.K., Wong K.L., Chan T.K., and Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study Gastroenterology 100 1 1991 182 188
38. Louisirirotchanakul S., Kanoksinsombat C., Theamboonlert A., Puthavatana P., Wasi C., and Poovorawan Y. Mutation of the "a" determinant of HBsAg with discordant HBsAg diagnostic kits Viral Immunol 17 3 2004 440 444
39. Feb Marsman W.A., Wiesner R.I.L., Batts K.P., Poterucha J.J., Porayko M.K., Niesters H.G., and Zondervan P.E. Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus Hepatology 25 2 1997 434 438
40. Jun Mason A.L., Xu L., Guo L., Kuhns M., and Perrillo R.P. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen Hepatology 27 6 1998 1736 1742
41. Apr Michalak T.I. Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model Review Immunol Rev 174 2000 98 111
42. Mar Michalak T.I., Pardoe I.U., Coffin C.S., Churchill N.D., Freake D.S., Smith P., and Trelegan C.L. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis Hepatology 29 3 1999 928 938
43. Nov Minuk G.Y., Sun D.F., Greenberg R., Zhang M., Hawkins K., Uhanova J., and Gutkin A. Occult hepatitis B virus infection in a North American adult hemodialysis patient population Hepatology 40 5 2004 1072 1077
44. Mar Mutimer D., Shaw J., Neuberger J., Skidmore S., Martin B., Hubscher S., and McMaster P. Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis Gut 36 3 1995 433 436
45. Nalpas B., Berthelot P., Thiers V., Duhamel G., Courouce A.M., Tiollais P., and Brechot C. Hepatitis B virus multiplication in the absence of usual serological markers. A study of 146 chronic alcoholics J Hepatol 1 2 1985 89 97
46. Nirei K., Kaneko M., Moriyama M., and Arakawa Y. The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen Intervirology 43 2 2000 95 101
47. May Ogata N., Miller R.I.L., Ishak K.G., and Purcell R.I.L. The complete nucleotide sequence of apre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees Virology 194 1 1993 263 276
48. Feb Pao C.C., Yang W.L., Wu S.Y., Lai G.M., Shih L.Y., Sun C.F., and Liaw Y.F. Presence of hepatitis B virus DNA in serum of surface-antigenseronegative immunocompromised patients J Clin Microbiol 25 2 1987 449 451
49. Sep Pariente E.A., Goudeau A., Dubois F., Degott C., Gluckman E., Devergie A., and Brechot C. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation Dig Dis Sci 33 9 1988 1185 1191
50. Jul 12 Paterlini P., Gerken G., Nakajima E., Terre S., D'Errico A., Grigioni W., and Nalpas B. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen N Engl J Med 323 2 1990 80 85
51. Jan Paterlini P., Driss F., Nalpas B., Pisi E., Franco D., Berthelot P., and Brechot C. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area Hepatology 17 1 1993 20 29
52. Feb Paterlini P., Poussin K., Kew M., Franco D., and Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma Hepatology 21 2 1995 313 321
53. Jan Pollicino T., Squadrito G., Cerenzia G., Cacciola I., Raffa G., Crax A., and Farinati F. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection Gastroenterology 126 1 2004 102 110
54. Jan Protzer-Knolle U., Naumann U., Bartenschlager R., Berg T., Hopf U., Meyer zum Buschenfelde K.H., and Neuhaus P. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation Hepatology 27 1 1998 254 263
55. Mar Raimondo G. Occult hepatitis B virus infection and liver disease: fact or fiction? Review J Hepatol 34 3 2001 471 473
56. Rehermann B., Ferrari C., Pasquinelli C., and Chisari T.V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response Nat Med 2 1996 1104 1108
57. Aug Saito T., Shinzawa H., Uchida T., Kawamata O., Honma S., Watanabe H., and Shao L. Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B J Med Virol 58 4 1999 325 331
58. Oct Sheu J.C. Molecular mechanism of hepatocarcinogenesis Review J Gastroenterol Hepatol 12 9-10 1997 S309 S313
59. Jun 1 Shintani Y., Yotsuyanagi H., Moriya K., Fujie H., Tsutsumi T., Takayama T., and Makuuchi M. The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C Cancer 88 11 2000 2478 2486
60. Aug Sterneck M., Gunther S., Santantonio T., Fischer L., Broelsch C.E., Greten H., and Will H. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation Hepatology 24 2 1996 300 306
61. Feb Stransky J., Malina L., Cieslarova B., Stritesky J., Putova I., and Horak J. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda Acta Virol 44 1 2000 23 28
62. Sep Sugawara Y., Makuuchi M., and Takada K. Detection of hepatitis B virus DNA in tissues of hepatocellular carcinomas related to hepatitis C virus which are negative for hepatitis B virus surface antigen Scand J Gastroenterol 34 9 1999 934 938
63. Nov-Dec Tabor E., Hoofnagle J.H., Smallwood L.A., Drucker J.A., Pineda-Tamondong G.C., Ni L.Y., and Greenwalt T.J. Studies of donors who transmit posttransfusion hepatitis Transfusion 19 6 1979 725 731
64. Oct Takeuchi M., Okamoto E., and Fujimoto J. In Japanese Detection of HBV-DNA from hepatocellular carcinoma by polymerase chain reaction Nippon Rinsho 53 1995 718 722 In Japanese
65. Feb Tanaka Y., Esumi M., and Shikata T. Persistence of hepatitis B virus DNA after serological clearance of hepatitis B virus Liver 10 1 1990 6 10
66. Jul Teo E.K., Han S.H., Terrault N., Luketic V., Jensen D., Keeffe E.B., Lok A.S. HBV OLT Study Group Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients Hepatology 34 1 2001
67. Dec 3 Thiers V., Nakajima E., Kremsdorf D., Mack D., Schellekens H., Driss F., and Goudeau A. Transmission of hepatitis B from hepatitis- Bseronegative subjects Lancet 2 8623 1988 1273 1276
68. Aug Uchida T., Kaneita Y., Gotoh K., Kanagawa H., Kouyama H., Kawanishi T., and Mima S. Hepatitis C virus is frequently coinfected with serum markernegative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection J Med Virol 52 4 1997 399 405
69. Jan Villa E., Grottola A., Buttafoco P., Trande P., Merighi A., Fratti N., and Seium Y. Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B Dig Dis Sci 40 1 1995 8 13
70. Jan 27 Wachs M.E., Amend W.J., Ascher N.L., Bretan P.N., Emond J., Lake J.R., and Melzer J.S. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors Transplantation 59 2 1995 230 234
71. Apr 18 Wright T.L., Mamish D., Combs C., Kim M., Donegan E., Ferrell L., and Lake J. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis Lancet 339 8799 1992 952 955
72. Jan Wu J.C., Li C.S., Chen C.L., Sheng W.Y., Lee S.D., and Lo K.J. Factors associated with viremia and elevated transaminase levels in asymptomatic hepatitis D virus-infected risk groups J Med Virol 42 1 1994 86 90
73. Feb 16 Yu M.W., Yeh S.H., Chen P.J., Liaw Y.F., Lin C.L., Liu C.J., and Shih W.L. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men J Natl Cancer Inst 97 4 2005 265 272
74. Nov 24 Zheng X., Weinberger K.M., Gehrke R., Isogawa M., Hilken G., Kemper T., and Xu Y. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity Virology 329 2 2004 454 464